Affectis Pharmaceuticals AG Announces Target Validation Collaboration
with Mitsubishi Pharma
February 7, 2005 – News Release
Munich, Germany, – Affectis Pharmaceuticals AG announced today that
it has signed a collaboration agreement with Mitsubishi Pharma Corporation
for the development of novel therapeutics for the treatment of affective
disorders. more...
Download
German version
Neuronova AG Receives a Silent Partnership from tbg Technologie-Beteiligungs-Gesellschaft
mbH and Announces Renaming to Affectis Pharmaceuticals AG
January 31, 2005 – News Release
Munich, Germany – Neuronova AG, a biopharmaceutical company developing
novel drugs against depression and anxiety, has received a grant of €
750,000 from Germany’s tbg Technologie-Beteiligungs-Gesellschaft
mbH, a state funding organisation. Furthermore, Neuronova has officially
changed its name to Affectis Pharmaceuticals AG. more...
Download German version
back to latest News 2005